
A significant increase in UK audit fees should encourage smaller firms to challenge the dominance of the Big Four, the UK chairman of EY stated.
According to the Financial Times, Steve Varley, who has been chairman of EY UK since 2011, made the prediction as the Big Four auditor that charging companies more for vetting their books had helped lift annual profits. Over the summer, EY warned its largest listed British clients, which include Vodafone, Burberry, and Aston Martin Lagonda, that they would have to pay more for audits because of “unprecedented market forces.”
The UK accounting industry faces the largest overhaul in decades amid intense scrutiny from politicians and regulators.
“The reaction from clients has been positive overall, as boards know it will deliver higher quality audits,” Mr Varley said of the jump in fees. “None of them want to get an invitation to appear before a select committee inquiry.”
The rise in audit fees being charged by EY has been mirrored by Deloitte, PwC, and KPMG, which together make up the Big Four accountants. Last year Grant Thornton, a mid-tier firm, dropped out of competing for the audits of FTSE 350 companies, citing the high cost of pitching, comparatively low fees, and the likelihood it would lose out to a Big Four firm.
Mr Varley said EY was conducting “various scenario planning,” including for a forced split of its audit and advisory functions, which is being considered by the British government.
“We believe the right set of comprehensive changes are needed to address corporate reporting, the scope of the audit, a strengthened regulator, and the accountability and regulation of both auditors and company directors,” Mr Varley said.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas